Therapeutic Solutions International Inc (TSOI)

[centsability4me]

DD / Share Structure

TSOI products = 12 - 5 Biologics , 6 Nutraceuticals , and 1 Pharmaceutical

TSOI nutraceutical products released from granted patent :
Projuvenol, NanoStilbene, DermalStilbene, IsoStilbene , NeuroStilbene, Alpha Lipoic Acid .
https://patents.google.com/patent/US9682047B2/en

4 TSOI nutraceutical products for sale online :
Projuvenol,Nanostilbene,DermalStilbene, NeuroStilbene.
http://www.youcanordernow.com/

5 Biologics ,1 Pharmaceutical licensed to Pan Am Cancer Treatment Center in Mexico :
http://ih.advfn.com/p.php?pid=nmona&article=77606645
http://ih.advfn.com/p.php?pid=nmona&article=77309980
http://ih.advfn.com/p.php?pid=nmona&article=77635806

Pan Am Cancer Treatment Center Introductory Video :

StemVacs Phase 1 clinical trials @ Pan Am Cancer Treatment Center in Mexico
Announced 5/1/18 :
http://ih.advfn.com/p.php?pid=nmona&article=77309980
for TSOI Right To Try Clinic future opening in USA .
https://ih.advfn.com/p.php?pid=nmona&article=77684969
Completed 9/4/18
Results :
https://ih.advfn.com/p.php?pid=nmona&article=78186786

Pilot pharmacokinetic trial of NanoStilbene for dosage /efficacy
Announced - 5/15/18 :
http://ih.advfn.com/p.php?pid=nmona&article=77431704
Completed - 7/2/18
Results :
http://ih.advfn.com/p.php?pid=nmona&article=77784227

Wes Chandler to Lead on CTE :
https://ih.advfn.com/p.php?pid=nmona&article=78119448

Therapeutic Solutions International Recruits NFL Chargers Hall of Famer Wes Chandler to Lead NeuroStilbene for Chronic Traumatic Encephalopathy in Football Players

Company to Advance NeuroStilbene Product for High-Performance Athletes
Susceptible to Head Injuries

A small pilot study is in the planning stages to be performed under the direction of Dr. Santosh Kesari at John Wayne Cancer Institute in Santa Monica CA. by conducting a clinical trial assessing the effects of pterostilbene in modulating immune response and inflammatory parameters in a group of advanced solid tumor cancer patients.
http://ih.advfn.com/p.php?pid=nmona&article=78098528

A small pilot study is in the planning stages to be performed under the direction of Dr. Nassir Azimi in San Diego CA. by conducting a study using NanoStilbene in a group of heart attack patients :
http://ih.advfn.com/p.php?pid=nmona&article=78098528

TSOI patent portfolio :
http://therapeuticsolutionsint.com/?page_id=68

More DD Here : (PR history,continuity,and company-related links)
https://investorshub.advfn.com/Therapeutic-Solutions-International-Inc-TSOI-13526/

Share Structure : https://www.otcmarkets.com/stock/TSOI/security
AS - 1.5 B common , 5 M preferred - https://www.nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=LvtIoYTPV6wB1RIovm008A%253d%253d&nt7=0
IO - 918,152,752
Restricted - 784,040,972
Unrestricted - 134,111,780
Float - 70,343,547
SEC Filings :https://www.sec.gov/cgi-bin/browse-edgar?company=therapeutic+solutions+international&match=contains&action=getcompany